IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Svennilson Peter

Q3 2020 Holdings

Filed 2020-11-04 | 11 holdings | $1.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$286.7K18,017,93223.4%
Revolution Medicines Inc(RVMD)COM76155X100$277.6K7,977,38422.7%
Nurix Therapeutics Inc(NRIX)COM67080M103$235.8K6,755,88119.2%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$181.3K5,630,49714.8%
Constellation Pharmceticls I(CNST)COM210373106$122.6K6,051,37610.0%
Oric Pharmaceuticals Inc.(ORIC)COM68622P109$119.3K4,768,1819.7%
Gritstone Oncology Inc(2JQ)COM39868T105$2.3K869,4930.2%